Increasing evidence implicates interactions between Abeta-peptides and membrane lipids in Alzheimer's disease. To gain insight into the potential role of the free amino group of the N-terminus of Abeta29-42 fragment in these processes, we have investigated the ability of Abeta29-42 unprotected and Abeta29-42 N-protected to interact with negatively-charged liposomes and have calculated the interaction with membrane lipids by conformational analysis. Using vesicles mimicking the composition of neuronal membranes, we show that both peptides have a similar capacity to induce membrane fusion and permeabilization. The fusogenic effect is related to the appearance of non-bilayer structures...
There are strong implications that Amyloid beta (Aβ) peptide causes neurotoxicity in Alzheimer's dis...
The peptide amyloid amp; 946; A amp; 946; interacts with membranes of cells in the human brain an...
The interaction of the native Alzheimer's peptide C-terminal fragment Abeta (29-42), and two ...
Increasing evidence implicates interactions between Abeta-peptides and membrane lipids in Alzheimer'...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
Amyloid amp; 946; peptides interact with cell membranes in the human brain and are associated with ...
AbstractAmyloid beta (Aβ) peptides, produced through endo-proteolytic cleavage of amyloid precursor ...
Amyloid peptide (Abeta) is a 40/42-residue proteolytic fragment of a precursor protein (APP), implic...
The toxicity of amyloids, as Abeta1-42 involved in Alzheimer disease, is a subject under intense scr...
A series of natural peptides and mutants, derived from the Alzheimer beta-amyloid peptide, wa...
In a previous work, we predicted and demonstrated that the 29-42-residue fragment of beta-amy...
One of the hallmarks of Alzheimer’s disease is the formation of senile plaques, primarily consisting...
Alzheimers disease is characterized by the aggregation and deposition of the Abeta peptide. This 40 ...
The peptide amyloid amp; 946; A amp; 946; interacts with membranes of cells in the human brain an...
There are strong implications that Amyloid beta (Aβ) peptide causes neurotoxicity in Alzheimer's dis...
The peptide amyloid amp; 946; A amp; 946; interacts with membranes of cells in the human brain an...
The interaction of the native Alzheimer's peptide C-terminal fragment Abeta (29-42), and two ...
Increasing evidence implicates interactions between Abeta-peptides and membrane lipids in Alzheimer'...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
The 39-42 amino acid long, amphipathic amyloid-beta peptide (Abeta) is one of the key components inv...
Amyloid amp; 946; peptides interact with cell membranes in the human brain and are associated with ...
AbstractAmyloid beta (Aβ) peptides, produced through endo-proteolytic cleavage of amyloid precursor ...
Amyloid peptide (Abeta) is a 40/42-residue proteolytic fragment of a precursor protein (APP), implic...
The toxicity of amyloids, as Abeta1-42 involved in Alzheimer disease, is a subject under intense scr...
A series of natural peptides and mutants, derived from the Alzheimer beta-amyloid peptide, wa...
In a previous work, we predicted and demonstrated that the 29-42-residue fragment of beta-amy...
One of the hallmarks of Alzheimer’s disease is the formation of senile plaques, primarily consisting...
Alzheimers disease is characterized by the aggregation and deposition of the Abeta peptide. This 40 ...
The peptide amyloid amp; 946; A amp; 946; interacts with membranes of cells in the human brain an...
There are strong implications that Amyloid beta (Aβ) peptide causes neurotoxicity in Alzheimer's dis...
The peptide amyloid amp; 946; A amp; 946; interacts with membranes of cells in the human brain an...
The interaction of the native Alzheimer's peptide C-terminal fragment Abeta (29-42), and two ...